Cell transplantation and diabetes: New sites, new devices

January 22, 2009

Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s. In recent years, research has focused on the anatomical sites best suited for hosting transplanted islet cells. Experimental sites have included the spleen, liver, peritoneal cavity, omentum, subcutaneous tissues and gastric submucosa. However, many transplant attempts at a variety of anatomical sites have failed because of a variety of complications.

While transplanting islet cells into the liver is current practice, improvements in biomedical devices have improved the overall success rates of islet transplantation. Recent advances in islet transplantation are discussed in the January issue of Cell Transplantation (Vol. 17 No.9).

Which anatomical sites are best for islet transplantation?

A review evaluating both anatomical site choice for islet cell transplantation and an ideal source of islet cells was the focus of a report by Dr. Dirk Van der Windt and colleagues at the Thomas E. Starzl Transplantation Institute at the University of Pittsburgh Medical Center. They concluded that transplantation into the liver "may not provide the conditions favoring optimum islet survival."

"Islet transplantation into the portal vein is current clinical practice," said Van der Windt. "However, this site has several characteristics that can hamper islet engraftment and survival."

According to Van der Windt, low oxygen tension and immune and inflammatory responses are among factors that can account for islet cell loss soon after transplantation. Thus, alternative anatomical sites for islet transplantation, sites offering maximum engraftment potential, the efficacious use of insulin and patient safety, are needed.

"The most physiological - and therefore perhaps most supportive, microenvironment for islets - is the pancreas itself," said Van der Windt and co-authors.

They also speculate on the value of porcine islet cells for transplantation, suggesting that these cells offer greater opportunities for selecting a donor at an age when the islets have favorable properties, when islet-like cell clusters isolated from fetal or neonatal piglets retain the ability to mature and proliferate. In addition, these cells are believed to be less immunogenic than adult islet cells and more resistant to hypoxia.

Van der Windt and colleagues suggest that porcine islet cells can provide an unlimited source of islets and in quantities that may satisfy the metabolic requirements of diabetic patients. Too, they are able to produce insulin that both functions in humans and offers opportunities for genetic modification that may help overcome some of the unfavorable site-specific conditions.

"These types of islets may have a better survival potential at different recipient sites," added Van der Windt.

Contact: Dr. Dirk Van der Windt, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, vanderwindtd@upmc.edu,

Engineering a bioartificial pancreas

Another review by Dr. Cherie Stabler and colleagues from the Diabetes Research Institute and the Department of Biomedical Engineering at the University of Miami (Florida), evaluated the engineering of bio-hybrid devices and encapsulation technologies that may aid in the success of islet transplants. According to the researchers, the transplantation of islet cells into the portal vein of the liver has presented several challenges. Overcoming those challenges means recognizing important issues such as vascularization, mechanical protection, device design, biomaterial selection and quality control in device engineering.

"A recent focus has been to redesign bio-hybrid devices that promote vascularization and effective nutrient delivery to prevent islet cell necrosis and at the same time minimize device volumes," said Stabler.

According to Stabler, one bio-hybrid design has been fabricated for pre-vascularization to afford maximum nutrient delivery and minimal exposure to inflammatory agents. At the same time, macrodevices, such as hollow fibers, have also been used for cell loading.

"The combination of these two treatments increased vascularization and blood flow around the bioartificial pancreas when compared to control implants," noted Stabler.

Encapsulation is also a technique for minimizing both immune response and the need for high dose immunosuppressive protocols. By coating the surface of the cell with semi-permeable biomaterial, the ability of host cells to recognize surface antigens on implanted cells is impaired and provides a barrier between the host and transplanted cells. Masking immune recognition also opens the possibility for xenotransplantation.

"Biomaterials used for encapsulation should be well-characterized, pharmaceutical grade and verified as pyrogen and endotoxin-free," explained Stabler. "It is critical to establish guidelines for generating capsules optimized for biocompatibility, immunoprotection and islet function."

Researchers supported the use of the portal vein as a site for islet transplantation, but noted that there are issues with injecting encapsulated cells into the liver. Finally, the research team suggested decreasing capsule size to nano-scale and combining PEGylation coating of capsules with a layer of poly(ethylene) glycol molecules with low-dose immunosuppression to improve engraftment and long-term function.

Contact: Dr. Cherie Stabler, Department of Biomedical Engineering, Director, Tissue Engineering and Nanotechnlogy Laboratory, Diabetes Research Institute, University of Miami, 1450 NW 10th Ave., Miami, FL. 33136. cstabler@med.miami.edu

"These articles published in the current issue of Cell Transplantation offer an unique overview on some of the most promising front line research in islet transplantation: the identification of new sites for transplant and of new approaches for the bioengineering of pancreatic islets," said Dr. Federico Bertuzzi, head of the Islet Transplant Program at the Unità di Diabetologia, Ospedale Niguarda in Milan, Italy and a Cell Transplantation editorial board member. "Taken together, these exciting new strategies demonstrated that two main problems of islet transplantation, poor engraftment and immune recognition, can now be better prevented than in the past. Accordingly, islet transplantation appears a feasible therapeutical option for type 1 diabetes mellitus."

Cell Transplantation Center of Excellence for Aging and Brain Repair

---

---

	Manual of Stem Cell and Bone Marrow Transplantation (Cambridge Medicine) by Joseph H. Antin MD (Author), Deborah Yolin Raley (Author) Over the past 35 years, stem cell and bone marrow transplantation have evolved from experimental therapies to well-established and widely used treatments for a variety of malignant and nonmalignant conditions. This is a practical pocket manual for all members of the stem cell and bone marrow transplant team, based on a popular in-house handbook used at the Dana-Farber Cancer Institute. The manual covers all aspects of the transplantation process, from stem cell processing through management of transplant-related complications. Evaluation and counseling of patients and donors, preventative care, and conditioning regimens are also covered, making this an ideal resource for nurses as well. The text is handily arranged in outline format to maximize the usefulness and convenience of this...
	Thomas' Hematopoietic Cell Transplantation by Frederick R. Appelbaum (Editor), Stephen J Forman (Editor), Robert S. Negrin (Editor), Karl G. Blume (Editor) This outstanding reference source on bone marrow transplantation has become recognised as the bible in the field. This fourth edition has been fully revised to reflect latest developments, and now features over 500 illustrations, including a colour plate section. The need for this new edition cannot be overstated - more than 13,000 new cases per year of haematopoietic stem cell transplantation have been reported to the International Bone Marrow Transplant Registry The original editor, Donnall Thomas, was a pioneer in stem cell research and won the 1990 Nobel Prize for his discoveries concerning organ and cell transplantation in the treatment of human diseases. The book also now includes a fully searchable CD with PDFs of the entire content.
	Allogeneic Stem Cell Transplantation (Current Clinical Oncology) by Mary J. Laughlin (Editor), Hillard M. Lazarus (Editor) Internationally recognized physicians and researchers review both the basics of allogeneic stem cell transplantation and recent advances in the field, particularly as they relate to antitumor effects and graft-versus-host disease They also provide unique decision-tree analyses to guide clinicians in selecting and managing their allogeneic transplant patients. The innovations discussed cover a variety of areas, ranging from stem cell mobilization in normal donors, to indications for allogeneic transplantation other than hematologic malignancies, to the use of nonmyeloablative conditioning regimens. The authors also explore new developments in the optimal selection of unrelated allogeneic grafts (e.g., matched unrelated donor, partially mismatched family member, or umbilical cord blood),...
	Hematopoietic Stem Cell Transplantation in Clinical Practice, 1e by Jennifer G. Treleaven MD FRCP FRCPath (Author), A. John Barrett MD FRCP FRCPath (Author) A guide to the practice of stem cell transplantation, its status in the treatment of various disorders and the problems that arise after transplantation, aimed at the whole transplant team.An up to date guide to best practice in the use of stem cell transplantation, covering current status in the treatment of malignant and non-malignant conditions, practical aspects and problems such as infection and graft versus host disease.Has a practical, accessible approach with free use of algorithms, list tables.Aimed at the whole transplant team - this is an interdisciplinary field.International contributor team with editors in the UK and USA.Illustrated in colour throughout.
	The Stem Cell Hope: How Stem Cell Medicine Can Change Our Lives by Alice Park (Author) A landmark book by the senior science writer at Time magazine introduces us to a medical breakthrough that can save our lives. Few people know much about stem cell research beyond the ethical questions raised by using embryos. But in the last decade, stem cell research has made huge advances toward eliminating some of our most intractable diseases. Now this sweeping and accessible book introduces us to this cutting-edge science that will revolutionize medicine and change the way we think about and treat disease. Alice Park takes us from stem cell's controversial beginnings to the recent electrifying promise of being able to create the versatile cells without using embryos at all. She shows us how stem cells give researchers an unprecedented ability to study disease while...
	100 Questions & Answers About Bone Marrow and Stem Cell Transplantation by Ewa Carrier (Author), Gracy Ledingham (Author) For People Fighting Many Kinds Of Disease, Bone Marrow Transplantation Or Stem Cell Transplantation May Be The Only Realistic Chance Of A Cure -- But The Procedure Is Complicated And Frightening, With Many Long-Term Ramifications. How Do You Decide Whether This Method Of Treatment Is For You? Along With Your Physician's Advice, Let 100 Questions And Answers About Bone Marrow And Stem Cell Transplantation Be Your Guide. It Is The Only Book That Offers The First-Hand Experiences Of A Patient And The Perspective Of A Transplant Doctor To Provide You With Authoritative, Practical Answers To Your Questions About Treatment Options, Post-Treatment Quality Of Life, Sources Of Support, And Much More. This Book Is An Invaluable Resource For Anyone Considering A Bone Marrow Or Stem Cell...
	Tissue and Cell Processing: An Essential Guide by Deirdre Fehily (Author), Scott A. Brubaker (Author), John N. Kearney (Author), Lloyd, Jr. Wolfinbarger (Author) By presenting the latest technological advances and growing national and international regulation, this new book explores state-of-the-art developments in the challenging field of tissue and cell processing. It provides a guide to easier and safer practice in operational principles of preservation, decontamination, and sterilization. Nearly half of the book is devoted completely to tissue- or cell-specific issues relating to processing. With lists of learning points and case studies which consist of sample processing protocols, descriptions of where processing went wrong, sample risk assessments, or validation studies, the authors help you find specific information fast.
	Blood And Marrow Stem Cell Transplantation: Principles, Practice, And Nursing Insights by Susan Ezzone (Author), Kim Schmit-Pokorny (Author) Blood and Marrow Stem Cell Transplantation, Third Edition serves as a convenient reference for oncology nurses caring for blood and marrow stem cell transplantation recipients. The Third Edition has been updated and revised to reflect the most current research related to the past, present, and future of blood and marrow stem cell transplants. This resource covers everything from preparing for transplantation, to recovery-related issues and delayed outcomes. Basic background information on transplantation procedures and processes are provided, along with in-depth coverage of pulmonary, cardiac, renal and hepatic, neurologic, and hematologic effects. A chapter devoted to controversial ethical issues is also provided. Blood and Marrow Stem Cell Transplantation, Third Edition presents...
	Cell Transplantation: New Research by David J. Belgaris (Editor), Alyson N. Savarese (Editor) In this book, the authors gather and present topical research in the study of cell transplantation. Topics discussed in this compilation include cell transplantation in chronic kidney disease; dendritic cells in allogenic hematopoietic cell transplantation; islet cell transplantation replacing beta cells that produce insulin in a diabetes cure; ocular surface reconstruction using cellular therapies; cell therapy on ischemic flaps; and, new therapeutic strategy for veno-occlusive disease after hematopoietic stem cell transplantation.
	Hematopoietic Stem Cell Transplantation, An Issue of Pediatric Clinics, 1e (The Clinics: Internal Medicine) by Max J. Coppes MD PhD MBA (Author), Terry J. Fry MD (Author), Crystal L. Mackall MD (Author) The subject of Pediatric Bone Marrow Transplantation is reviewed in this issue of Pediatric Clinics. Guest Editors Drs. Max Coppes, Terry Fry, and Crystal Mackall have assembled a panel of experts who offer reviews on topics including Allogeneic BMT for leukemia, GVL in pediatric leukemia, Stem cell source and outcome following BMT in children, Acute GVHD in children, Chronic GVHD in children, BMT for Hemoglobinopathies, BMT for immunodeficiency, BMT for rheumatologic disorders and other benign diseases, Autologous and Allogeneic BMT for solid tumors, Late effects following BMT, Cell therapies/vaccines for malignancy and infections, BMT for metabolic disorders, BMT for bone marrow failure syndromes, and Immunotherapy in the context of SCT.